ProfileGDS4459 / ENSG00000149806
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 89% 88% 95% 93% 92% 88% 95% 95% 95% 94% 89% 93% 91% 90% 94% 89% 88% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.0489
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.8788
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.395
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.5493
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.7492
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 67.0388
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.1795
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.2295
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.2195
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.9394
GSM623474group B, liver allograft wedge biopsie placebo treatment 17.2189
GSM623475group B, liver allograft wedge biopsie placebo treatment 27.9593
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.5291
GSM623477group B, liver allograft wedge biopsie placebo treatment 47.0490
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.1194
GSM623479group B, liver allograft wedge biopsie placebo treatment 67.0389
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.8488